YTEN News and Press, Yield10 Bioscience Inc. From 10/01/20

WOBURN, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it has completed the harvest for its 2020 Field Test Program for Camelina and canola trials conducted in the United States and Canada. Yield10’...

The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with this Read more ...

HC Wainwright initiated Yield10 Bioscience (NASDAQ: YTEN )  +2.7% AH, with Buy rating, price target of $25. More news on: Yield10 Bioscience, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Gainers:  Yield10 Bioscience (NASDAQ: YTEN ) +60% . More news on: Yield10 Bioscience, Inc., Renren Inc., Virtusa Corporation, Stocks on the move, , Read more ...

Yield10 Bioscience (NASDAQ: YTEN ) +81% . More news on: Yield10 Bioscience, Inc., Virtusa Corporation, RH, Stocks on the move, , Read more ...

WOBURN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference. The conference is being held on Septemb...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

WOBURN, MA / ACCESSWIRE / August 27, 2020 / Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a virtual corporate presentation at the LD 500 Virtual Confe...

WOBURN, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 835,000 shares of its common stock at a public offering price of $4.25 per sh...

Yield10 Bioscience (NASDAQ: YTEN ) has priced its public offering of 835,000 common shares at $4.25/share, for gross proceeds of ~$3.5M. More news on: Yield10 Bioscience, Inc., Healthcare stocks news, , Read more ...